| Date | Title | Description |
| 08.07.2026 | Genesys University Seed Fund Holds First Close With Over $30 Million In Commitments | The University of Toronto, McMaster University, Venture Ontario, and Genesys Capital announced the creation of a new early-stage life sciences venture capital fund. The Genesys University Seed Fund has held a first close representing over $... |
| 24.05.2026 | Blank Bio Ignites Precision Oncology with $7.2M Seed Round | Blank Bio secured $7.2M in seed funding. This investment propels RNA foundation models for precision oncology. A strategic partnership with PacBio will generate critical high-resolution long-read RNA sequencing data from patient tumors. Bla... |
| 21.05.2026 | Blank Bio: $7.2 Million Seed Raised To Advance RNA Foundation Models For Precision Oncology | Blank Bio announced the closing of a $7.2 million seed financing alongside a strategic collaboration with PacBio to advance RNA foundation models for precision oncology applications.
The San Francisco-based company is building foundation mo... |
| 19.05.2026 | Blank Bio: $7.2 Million Seed Financing Raised To Advance RNA Foundation Models For Precision Oncology | Blank Bio, an applied AI research lab focused on training foundation models for RNA, announced the closing of a $7.2 million seed financing round along with a strategic collaboration with Pacific Biosciences to advance RNA foundation models... |
| 22.05.2024 | Breakthrough Properties to Welcome Three Mission-Driven Biotech Companies to One Canal Development in the Heart of Cambridge | Leases with Deep Genomics, Larkspur Biosciences and Incendia Therapeutics Executed Upon Substantial Construction Completion, Anchoring Breakthrough's East Cambridge Waterfront Building
BOSTON, May 22, 2024 /PRNewswire/ -- Breakthrough Prope... |
| 06.08.2021 | Deep Genomics Closes $180 Million In Series C Funding | Deep Genomics announced recently that they have closed a $180 million Series C financing round. These are the details.
Deep Genomics – a leading artificial intelligence (AI) therapeutics company – announced recently that they have closed a ... |
| 02.08.2021 | Deep Genomics raises $180M for AI-enabled RNA therapeutic discovery | Photo: Kwanchai Lerttanapunyaporn/Getty Images |
| 28.07.2021 | Deep Genomics : Raises $180M in Series C Financing | Deep Genomics, the leading artificial intelligence (AI) therapeutics company, announced today the closing of a $180 million Series C financing round. SoftBank Vision Fund 2* led the financing with participation from new investors, Canadian ... |
| 28.07.2021 | AI-driven Deep Genomics gets $180M to turn biology into informational medicines | Drug discovery and development is advancing by leaps and bounds as genetic medicines progress under a growing number of biotech companies. In the view of Brendan Frey, founder and CEO of startup Deep Genomics, while the drugs of the 20th ce... |
| 28.07.2021 | Deep Genomics scores $180M to deliver AI-programmed RNA therapies | With COVID-19 vaccines making RNA-based medicines a household name, Deep Genomics is reaping some of the buzz—as well as $180 million in new funding for its efforts to develop “programmable” therapies.
By writing specific instructions into ... |
| 28.07.2021 | Deep Genomics scores $180M to deliver AI-programmed RNA therapies | With COVID-19 vaccines making RNA-based medicines a household name, Deep Genomics is reaping some of the buzz—as well as $180 million in new funding for its efforts to develop “programmable” therapies.
The artificial intelligence firm’s ser... |
| 28.07.2021 | Deep Genomics raises $180 million to automate drug discovery | Brendan Frey, the founder and chief executive of Deep Genomics, thinks the wrong people are developing new drugs to treat genetic diseases. In fact, he doesn’t think humans should be doing most of the work.
It’s Frey’s view that the next wa... |
| 28.07.2021 | Deep Genomics secures $226 million CAD led by SoftBank as it scales AI drug discovery platform | Deep Genomics has secured $226 million CAD ($180 million USD) as the startup has increased the number of drug candidates it has discovered using artificial intelligence (AI) and is eyeing clinic trials.
The financing was led by SoftBank Vis... |
| 23.03.2021 | Top 10 Medical Technology (MedTech) startups in Canada | Medical technology (MedTech), an industry that combines the power of technology with the capabilities of modern medical practices, is a sector that can by no means be overlooked in the world today. From the simple stethoscope to highly adva... |
| 31.08.2020 | Venture Capital: Founders guide to the basics | “As a decade of growth in venture capital investment falters amid uncertain economic conditions, one thing remains constant: VCs will keep searching for companies that do business in a way that’s never been done before.”– CB Insights.... |
| 16.01.2020 | Toronto-Based Deep Genomics Closes $40 Million In Funding | Toronto-based AI therapeutics company Deep Genomics announced it has raised $40 million in a new round of funding
Toronto-based AI therapeutics company Deep Genomics announced it has raised $40 million in a new round of funding. The proceed... |
| 08.01.2020 | Daily funding roundup - January 8th, 2020 | Midnite raised $2.5M; Fishbowl landed $5.3M; Legalpad has secured $10M; Deep Genomics closed $30M
Midnite: Midnite is an e-sports betting startup. Midnite has raised $2.5 million led by Makers Fund. Read more
Fishbowl: Fishbowl is a social ... |
| 07.01.2020 | Deep Genomics nabs $40M round, doubles down on AI and Wilson disease work | Canadian drug development company Deep Genomics has got off a $40 million series B round as it looks to double down on its rare genetic disease and artificial intelligence work.
Deep Genomics is one of an increasing number of biotech and dr... |
| 07.01.2020 | Deep Genomics raises $40 million Series B for AI drug discovery platform | Toronto-based AI therapeutics startup, Deep Genomics, has closed a $40 million Series B. This brings the company’s total funding to-date to $61 million.
The round was led by Future Ventures and received investments from Amplitude Ventures, ... |
| 07.01.2020 | Deep Genomics nabs $40M round, doubles down on AI and Wilson disease work | Canadian drug development company Deep Genomics has got off a $40 million series B round as it looks to double down on its rare genetic disease and artificial intelligence work.
Sponsored by Agilent Technologies
How would you like to win fr... |
| 27.09.2017 | Term Sheet — Wednesday, September 27 | 5 QS WITH A DEALMAKER
Good morning, Term Sheet readers.
Paid Content Securing the enterprise without boundaries From ExtraHop
Deeter has led investments in companies including, Twilio, Box, ProCore, and Tile. He’s personally backed more clo... |
| 26.09.2017 | Deep Genomics Raises $13M in Funding | Deep Genomics, a Toronto, Canada-based AI driven genetic medicine company, raised $13m in follow-on financing.
The round was co-led by Khosla Ventures with participation from True Ventures.
Founded in 2015 by Brendan Frey, CEO and scientifi... |
| 25.09.2017 | Toronto-based Deep Genomics raises $16 million from Khosla Ventures | Toronto-based Deep Genomics has raised $16 million CAD in funding led by Khosla Ventures, according to a report from The Globe and Mail.
Canadian astronaut Chris Hadfield and entrepreneur Michael Hyatt also invested in the company.
Deep Gen... |
| 17.09.2017 | We need small players to help shape the future of AI | Google, Alibaba, Facebook, Baidu, and other tech giants are leading the charge in developing and acquiring AI companies and talent. Many observers have expressed concern that the big players are dominating what will be one of the most impor... |
| 17.09.2017 | We need small players to help shape the future of AI | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Google, Alibaba, Facebook, Baidu, and other tech ... |
| 27.06.2017 | How AI can be a force for good | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
You probably know that by 2022 an estimated 5 mil... |
| 16.03.2017 | Advances in AI and ML are reshaping healthcare | Megh Gupta Contributor
Megh Gupta is a member of the investment team at OMERS Ventures.
Qasim Mohammad Contributor
Qasim Mohammad is a Toronto-based venture capitalist and a member of the investment team at OMERS Ventures.
More posts by thi... |
| 26.10.2016 | Toronto is proving to be a hotbed for machine learning | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
If you’re interested in learning about, investing... |
| 26.10.2016 | Toronto is proving to be a hotbed for machine learning | If you’re interested in learning about, investing in, or building a company involved in machine learning, Toronto should be on your radar. Here are five reasons why:
1. The Geoff Hinton Lab Mafia
If you’ve been following the industry, you l... |
| 02.04.2016 | Deep learning will be huge — and here’s who will dominate it | Artificial intelligence* is developing much faster than we thought. Just last month, Google’s DeepMind AI beat Lee Sedol, a legendary Go player, at his own game in a defining moment for the industry. What enabled this win is a relatively ne... |
| 02.04.2016 | Deep learning will be huge — and here’s who will dominate it | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Artificial intelligence* is developing much faste... |
| 17.12.2015 | Taking The Genome Further In Healthcare | Brendan Frey Contributor
Brendan Frey is the CEO and president of Deep Genomics.
Collecting genome data is reliable, fast and cheap. Yet, interpreting that data is unreliable, slow, and expensive — when it’s even possible.
Today, genome int... |
| 19.11.2015 | Daily funding roundup - November 19, 2015 | PresenceLearning raised $25M; UrbanClap scored $25M; Cinematique closed $3.5M funding
Touchable video platform Cinematique, announced on Thursday that it has closed $3.5 million in a funding round led by Pumori Capital, an investment adviso... |
| 18.11.2015 | Deep Genomics Closes Canadian $5M Seed Financing Round | Deep Genomics, a Toronto, Ontario, Canada-based deep learning and genome biology startup, closed a Canadian $5m seed financing round.
The round was led by True Ventures with participation from Bloomberg Beta and other global angel investors... |
| 18.11.2015 | Today in funding ($34M): Blueprint, Deep Genomics, Meta | A trio of Toronto-based startups have closed significant rounds, keeping the city in the Canadian startup spotlight. Here’s the latest on who raised how much, from whom.
Deep Genomics raises $5 million in seed funding
Deep Genomics, a Toron... |
| 22.07.2015 | This Startup Says AI Can Predict the Effects of Gene Editing | Groundbreaking gene editing techniques like CRISPR/Cas9 have recently experienced a sharp uptick in interest from researchers, and their fair share of scrutiny, too. But in a world where bespoke genetic mutations are not unheard of, how can... |
| - | Opportunities at the Intersection of Biology, Software, and Automation | Over the past two decades, we’ve seen hundreds of billions of dollars of market capitalization created by new software and infrastructure companies built at the intersection of mobile, data, and cloud computing.
Now, we’re in the middle of... |
| - | Welcoming Deep Genomics | A few months ago, Jon talked about our growing interest in investing in “core sciences”—including synthetic biology, neuroscience and healthcare.
Many of these recent investments are stealthy, but I am pleased today to announce our investm... |
| - | AI-driven Deep Genomics gets $180M to turn biology into informational medicines | Drug discovery and development is advancing by leaps and bounds as genetic medicines progress under a growing number of biotech companies. In the view of Brendan Frey, founder and CEO of startup Deep Genomics, while the drugs of the 20th ce... |
| - | Why We Believe in Toronto’s Founders and Startup Scene |
Periodically, we raise our heads out of the ocean to examine trends across the startup ecosystem. Lately, and on the heels of Voiceflow’s recent funding announcement, we’ve noticed an increase in high-quality deals and entrepreneurs, whom... |
| - | Founder-Focused Investing in Human Health and Biology | Recently, there have been a number of thoughtful blog posts on different models for funding emerging opportunities in human health and biology.
Biotech Researchers Venture Into the Wild to Start Their Own Businesses by Jorge Conde
The $10... |
